Is pulsed dosing the answer to treatment of Clostridium difficile infection?

Is pulsed dosing the answer to treatment of Clostridium difficile infection?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2018-03, Vol.18 (3), p.231-233
1. Verfasser: Gerding, Dale N
Format: Artikel
Sprache:eng
Schlagworte:
Antibiotics
Bacteroides fragilis
Clinical trials
Clostridium
Clostridium difficile
Dosage
Infections
Infectious diseases
Metronidazole
Microbiomes
Patients
Polymers
Prevention
Randomization
Recovery
Studies
Toxin A
Vancomycin
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 233
container_issue 3
container_start_page 231
container_title The Lancet infectious diseases
container_volume 18
creator Gerding, Dale N
description
doi_str_mv 10.1016/S1473-3099(17)30750-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1979964269</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309917307508</els_id><sourcerecordid>2007526516</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-19fd163da926a79c780498770e50d01819de4e716ef22505b1ca68e11da308973</originalsourceid><addsrcrecordid>eNqFkUFPFTEUhRsjEXz6EyRN3OBioLfTaacrYl4USF7iQlw3pb2jJTPTR9vR-O8p7yELF7DqTfPdc0_OIeQDsFNgIM--g1Bt0zKtT0B9apnqWNO_Ikf1WzRCdOr1bt4jh-RtzreMgQIm3pBDrrlquWJHZHOV6XYZM3rqYw7zT1p-IbVz_oOJlkhLQlsmnAuNA12PMZcUfFgm6sMwBBdGpGEe0JUQ5_N35GCwVev947siP75-uV5fNptvF1frz5vGVUOlAT14kK23mkurtFM9E7pXimHHPIMetEeBCiQOnHesuwFnZY8A3ras16pdkZO97jbFuwVzMVPIDsfRzhiXbEArraXgUlf043_obVzSXN0ZLriAVkkNz1KsRstlVw2vSLenXIo5JxzMNoXJpr8GmHkoxexKMQ-JG1BmV4rp697xo_pyM6F_2vrXQgXO9wDW0H4HTCa7gLNDH1KN1vgYXjhxD_BYmQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007526516</pqid></control><display><type>article</type><title>Is pulsed dosing the answer to treatment of Clostridium difficile infection?</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>ProQuest Central UK/Ireland</source><creator>Gerding, Dale N</creator><creatorcontrib>Gerding, Dale N</creatorcontrib><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(17)30750-8</identifier><identifier>PMID: 29273270</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Antibiotics ; Bacteroides fragilis ; Clinical trials ; Clostridium ; Clostridium difficile ; Dosage ; Infections ; Infectious diseases ; Metronidazole ; Microbiomes ; Patients ; Polymers ; Prevention ; Randomization ; Recovery ; Studies ; Toxin A ; Vancomycin</subject><ispartof>The Lancet infectious diseases, 2018-03, Vol.18 (3), p.231-233</ispartof><rights>2018 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Mar 1, 2018</rights><rights>2018. Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-19fd163da926a79c780498770e50d01819de4e716ef22505b1ca68e11da308973</citedby><cites>FETCH-LOGICAL-c473t-19fd163da926a79c780498770e50d01819de4e716ef22505b1ca68e11da308973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2424137691?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978,64366,64368,64370,72220</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29273270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerding, Dale N</creatorcontrib><title>Is pulsed dosing the answer to treatment of Clostridium difficile infection?</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><subject>Antibiotics</subject><subject>Bacteroides fragilis</subject><subject>Clinical trials</subject><subject>Clostridium</subject><subject>Clostridium difficile</subject><subject>Dosage</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Metronidazole</subject><subject>Microbiomes</subject><subject>Patients</subject><subject>Polymers</subject><subject>Prevention</subject><subject>Randomization</subject><subject>Recovery</subject><subject>Studies</subject><subject>Toxin A</subject><subject>Vancomycin</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkUFPFTEUhRsjEXz6EyRN3OBioLfTaacrYl4USF7iQlw3pb2jJTPTR9vR-O8p7yELF7DqTfPdc0_OIeQDsFNgIM--g1Bt0zKtT0B9apnqWNO_Ikf1WzRCdOr1bt4jh-RtzreMgQIm3pBDrrlquWJHZHOV6XYZM3rqYw7zT1p-IbVz_oOJlkhLQlsmnAuNA12PMZcUfFgm6sMwBBdGpGEe0JUQ5_N35GCwVev947siP75-uV5fNptvF1frz5vGVUOlAT14kK23mkurtFM9E7pXimHHPIMetEeBCiQOnHesuwFnZY8A3ras16pdkZO97jbFuwVzMVPIDsfRzhiXbEArraXgUlf043_obVzSXN0ZLriAVkkNz1KsRstlVw2vSLenXIo5JxzMNoXJpr8GmHkoxexKMQ-JG1BmV4rp697xo_pyM6F_2vrXQgXO9wDW0H4HTCa7gLNDH1KN1vgYXjhxD_BYmQQ</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Gerding, Dale N</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>Is pulsed dosing the answer to treatment of Clostridium difficile infection?</title><author>Gerding, Dale N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-19fd163da926a79c780498770e50d01819de4e716ef22505b1ca68e11da308973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibiotics</topic><topic>Bacteroides fragilis</topic><topic>Clinical trials</topic><topic>Clostridium</topic><topic>Clostridium difficile</topic><topic>Dosage</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Metronidazole</topic><topic>Microbiomes</topic><topic>Patients</topic><topic>Polymers</topic><topic>Prevention</topic><topic>Randomization</topic><topic>Recovery</topic><topic>Studies</topic><topic>Toxin A</topic><topic>Vancomycin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerding, Dale N</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerding, Dale N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Is pulsed dosing the answer to treatment of Clostridium difficile infection?</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2018-03</date><risdate>2018</risdate><volume>18</volume><issue>3</issue><spage>231</spage><epage>233</epage><pages>231-233</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>29273270</pmid><doi>10.1016/S1473-3099(17)30750-8</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2018-03, Vol.18 (3), p.231-233
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_miscellaneous_1979964269
source Elsevier ScienceDirect Journals Complete - AutoHoldings; ProQuest Central UK/Ireland
subjects Antibiotics
Bacteroides fragilis
Clinical trials
Clostridium
Clostridium difficile
Dosage
Infections
Infectious diseases
Metronidazole
Microbiomes
Patients
Polymers
Prevention
Randomization
Recovery
Studies
Toxin A
Vancomycin
title Is pulsed dosing the answer to treatment of Clostridium difficile infection?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A48%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Is%20pulsed%20dosing%20the%20answer%20to%20treatment%20of%20Clostridium%20difficile%20infection?&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Gerding,%20Dale%20N&rft.date=2018-03&rft.volume=18&rft.issue=3&rft.spage=231&rft.epage=233&rft.pages=231-233&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(17)30750-8&rft_dat=%3Cproquest_cross%3E2007526516%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2007526516&rft_id=info:pmid/29273270&rft_els_id=S1473309917307508&rfr_iscdi=true